With the deal, Austin, Texas-based Function adds to its clinical lab offerings, allowing its members to schedule at-home or in-office blood draws.

MedStar Health will deploy PathAI's AISight for the more than 40 pathologists at its multi-site health system serving the Washington, D.C. area.

The company said its BD Onclarity HPV Self-Collection Kit will improve access to testing for human papillomavirus, which is the main cause of cervical cancer.

While the effort could bring new requirements to the reimbursement process, it could also make payments more standardized and ...

Cepheid's GeneXpert system displayed at a conference. NEW YORK – A decade ago, a molecular point-of-care test received CLIA waiver for the first time, ushering in what many thought would be a seismic ...

The researchers measured ctDNA in women with breast cancer over 70 years of age before beginning endocrine therapy and ...

NEW YORK – Shares of Caris Life Sciences were up as much as 6 percent Wednesday morning after the company on Tuesday evening shared finalized Achieve I study results for its multi-cancer early ...

NEW YORK – Laboratory Corporation of America said in a filing with the US Securities and Exchange Commission on Friday that it has entered into an agreement for a term loan of $750 million. The ...

Providers will be able to integrate Galleri into their workflows with a unified ordering experience, embedded physician network, and streamlined operational support. While the Karolinska researchers ...

NEW YORK – Fujirebio said Tuesday that its Lumipulse G NfL Blood test has received the CE mark under the EU In Vitro Diagnostic Regulation (IVDR). The test allows for quantitative measurement of the ...

Clinical labs are exploring new business opportunities as consumers take more control of their healthcare and bypass their ...